Vaginal estrogen therapy appears to be safe after early breast cancer in patients with HR-negative tumors and those with HR-positive tumors concurrently treated with tamoxifen, new data suggest.
A recent study discovered that breast cancer patients who took statins, medications that lower cholesterol, had notably lower mortality rates compared with those who did not use these drugs.
Several studies suggest that many breast cancer patients are not well prepared to move forward after a breast cancer diagnosis and subsequent treatments.
A safety analysis following a randomized phase 3 trial confirms that vomiting and nausea are common in patients who take the drug trastuzumab deruxtecan to treat HER2-low metastatic breast cancer.